A carregar...
SARS‐CoV‐2 S1 is superior to the RBD as a COVID‐19 subunit vaccine antigen
Since its emergence in December 2019, severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) has developed into a global pandemic within a matter of months. While subunit vaccines are one of the prominent options for combating coronavirus disease 2019 (COVID‐19), the immunogenicity of spike pr...
Na minha lista:
| Publicado no: | J Med Virol |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley and Sons Inc.
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7404424/ https://ncbi.nlm.nih.gov/pubmed/32691875 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jmv.26320 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|